Does Regence Cover Cialis?

How Regence Formularies Work

Regence BlueCross BlueShield operates multiple plan lines across Idaho, Oregon, Utah, and Washington. Each plan year brings a distinct formulary, and what is covered under an employer-sponsored PPO in Seattle may differ from an ACA Marketplace HMO in Boise. Understanding how the formulary system works is the first step before assuming Cialis is or is not covered.

Tiers and What They Mean for Your Cost

Most Regence formularies use a five-tier structure. Tier 1 covers preferred generics at the lowest copay, typically $5, $15 per fill. Tier 2 covers non-preferred generics and some preferred brands, usually $30, $60. Tier 3 is the standard brand tier, where Cialis historically lands, with copays ranging from $60 to $100 or more per fill. Tier 4 and Tier 5 apply to specialty drugs and non-formulary agents.

Generic tadalafil entered the U.S. Market in 2018 following patent expiration, and Regence plans quickly moved brand Cialis to non-preferred or even non-formulary status. The practical effect: if you are prescribed brand Cialis today, you will very likely pay substantially more out of pocket than if you accept a generic substitution.

The Role of Step Therapy

Step therapy requires you to try a lower-cost alternative before the plan will authorize a more expensive drug. For tadalafil specifically, most Regence plans apply step therapy in one of two ways. First, they require you to try generic tadalafil before authorizing brand Cialis. Second, some plans require documented failure of or contraindication to sildenafil (generic Viagra) before authorizing any tadalafil formulation for ED. This is common across commercial insurers and is endorsed as cost-effective by the American Urological Association's clinical practice guidelines.

Does Regence Cover Cialis for Erectile Dysfunction?

Coverage for ED specifically is where Regence most often draws a line. Erectile dysfunction is classified by most commercial payers, including Regence, as a condition that may be excluded under certain plan designs. Federal law does not require commercial insurers to cover ED medications, which gives Regence broad discretion.

Plans That Exclude ED Coverage Outright

Many employer-sponsored Regence plans include an explicit ED drug exclusion in the Summary of Benefits and Coverage (SBC). This exclusion typically lists phosphodiesterase-5 (PDE-5) inhibitors, which includes tadalafil, sildenafil, vardenafil, and avanafil, as non-covered. If your plan has this exclusion, a prior authorization will not overcome it. The denial will cite the exclusion, not a clinical criterion.

The FDA label for Cialis lists ED as a primary approved indication, but FDA approval does not obligate an insurer to cover a drug.

Plans That May Cover ED With Conditions

Some Regence plans, particularly those sold on the individual and small-group ACA Marketplace, do not carry a blanket ED exclusion. In these cases, tadalafil for ED may be covered at Tier 2 (generic) with prior authorization. Documentation that your physician commonly needs to submit includes a diagnosis of ED using ICD-10 code N52.xx, a description of the cause (organic, psychogenic, or mixed), any relevant comorbidities such as diabetes or cardiovascular disease, and confirmation that a trial of sildenafil either failed or is contraindicated.

A 2021 analysis published in JAMA Internal Medicine found that among commercially insured men with ED, roughly 40% faced a claim denial on first submission for a PDE-5 inhibitor. Resubmission with additional clinical documentation resolved the denial in approximately 55% of those cases. This suggests documentation quality matters significantly.

Does Regence Cover Cialis for BPH?

BPH coverage is where the answer becomes notably more favorable. Tadalafil 5 mg daily received FDA approval for BPH in 2011, and for the combination of BPH plus ED in the same approval cycle. Because BPH is classified as a medical condition rather than a "lifestyle" indication, Regence plans are far more likely to cover tadalafil under this diagnosis.

Clinical Criteria for BPH Authorization

To obtain prior authorization for tadalafil under BPH, Regence typically asks for:

• A documented International Prostate Symptom Score (IPSS) of 8 or higher
• A physician note confirming benign prostatic enlargement on digital rectal exam or ultrasound
• Confirmation that the patient has tried or has a contraindication to an alpha-blocker such as tamsulosin (Flomax) 0.4 mg daily for at least 4 to 6 weeks
• The specific tadalafil dose requested (2.5 mg or 5 mg daily for BPH)

The AUA/SUFU Benign Prostatic Hyperplasia Guideline (2023 update) states: "Clinicians may offer PDE5-inhibitor therapy to men with LUTS/BPH with or without erectile dysfunction." This guideline language directly supports a medical necessity argument if Regence denies coverage.

Comorbid ED and BPH

When a patient has both conditions diagnosed and documented, coverage prospects improve. ICD-10 allows co-coding of N40.1 (BPH with lower urinary tract symptoms) and N52.xx (ED). Submitting a prior authorization with both codes, backed by clinical notes addressing both diagnoses, gives the claim the strongest possible foundation. Some Regence plans specifically carve out ED-only coverage but cover tadalafil when BPH is the primary or co-primary indication.

How to Check Your Specific Regence Plan's Coverage

No single answer applies to every Regence member. Plans differ by state, employer contract, and plan year. Here is a step-by-step method for checking your own coverage before filling a prescription.

Step 1: Pull Your Summary of Benefits and Coverage

Log into your Regence member portal at regence.com and download the current-year SBC. Search the document for "erectile dysfunction," "sexual dysfunction," "PDE5," and "tadalafil." An explicit exclusion in this document almost always overrides any other consideration.

Step 2: Search the Drug Formulary

The formulary (also called the drug list) is a separate document from the SBC. Search for "tadalafil" and "Cialis" independently, because some plans list them differently. Note the tier, any quantity limits (common limits are 6 tablets per 30 days for as-needed dosing), and whether a prior authorization (PA) or step therapy (ST) flag appears next to the drug name.

Step 3: Call the Pharmacy Benefits Number

The member ID card lists a pharmacy benefits number, often a separate line from the medical benefits line. Ask the representative three specific questions: (1) Is tadalafil covered under my plan for ICD-10 code N52.9 (erectile dysfunction, unspecified)? (2) Is tadalafil covered for ICD-10 code N40.1 (BPH with LUTS)? (3) What clinical documentation does my prescriber need to submit for prior authorization?

Step 4: Ask Your Prescriber to Submit a PA

If tadalafil is formulary-covered but PA-required, your physician or their office staff submits a PA request directly to Regence. The prescriber's clinical notes, the diagnosis codes, any step therapy documentation, and the requested drug and dose are all part of the submission. Regence is required under most state regulations to respond to a standard PA within 3 business days and an urgent PA within 24 hours.

Prior Authorization for Cialis: What the Process Looks Like

Prior authorization is the single biggest barrier most Regence members encounter. The process is not designed to be punitive; it is a utilization management tool. It does create real delays.

What Regence Reviews During PA

The PA reviewer checks whether the requested drug is on the formulary, whether step therapy requirements have been met, and whether the submitted clinical notes support medical necessity. For tadalafil, "medical necessity" under Regence criteria generally means the diagnosis is supported by objective findings (lab work, exam notes, validated symptom scores) and the requested drug is the clinically appropriate choice given the patient's history.

If your prescriber submits a PA for brand Cialis when generic tadalafil is available and the formulary flags brand Cialis as non-preferred, the PA is almost certain to be denied unless the prescriber documents a specific reason brand is required (for example, a documented tolerance issue with a particular generic manufacturer's excipients, though this is rarely accepted without strong evidence).

Timelines and What to Do If PA Is Denied

Standard PA decisions at Regence take up to 3 business days. If the PA is denied, Regence must send a written denial with the specific reason. You then have the right to:

1. Request an internal appeal within 180 days. The appeal goes to a different reviewer, often a physician.
2. Request an expedited appeal if the condition is urgent.
3. Request an external independent review after exhausting internal appeals.

The National Patient Advocate Foundation has documented that patients who file formal appeals with complete medical records succeed in overturning denials at rates of 30% to 50% depending on the indication.

Cost Without Coverage: What Tadalafil Actually Costs

If coverage is denied or excluded, the out-of-pocket cost depends heavily on formulation and dose.

Generic Tadalafil Pricing

Generic tadalafil 5 mg (30 tablets, 30-day supply) retails at major pharmacy chains for approximately $30, $60 without insurance. With a GoodRx or similar discount coupon, costs at some pharmacies drop to $15, $25 per month. The 10 mg and 20 mg as-needed tablets cost somewhat more, typically $40, $80 per month for a quantity of 8 tablets.

The FDA's generic drug program confirms that generic tadalafil contains the same active ingredient, same strength, and same dosage form as brand Cialis and meets identical bioequivalence standards. There is no clinical reason to pay brand-name pricing for most patients.

Brand Cialis Pricing

Brand Cialis 5 mg (30 tablets) retails at approximately $400, $500 per month at the time of writing. Eli Lilly operates a patient assistance program for eligible uninsured or underinsured patients. Income thresholds and eligibility criteria change; current information is available directly through Lilly's website or through the NeedyMeds database.

Tadalafil Compared to Other PDE-5 Inhibitors on the Regence Formulary

Understanding where tadalafil sits relative to sildenafil, vardenafil, and avanafil matters for both coverage and clinical decision-making.

Sildenafil (Generic Viagra)

Sildenafil is approved for ED and, at different doses, for pulmonary arterial hypertension under the brand name Revatio. Because of the pulmonary hypertension indication, generic sildenafil is frequently Tier 1 or Tier 2 on Regence formularies. Some plans require a trial of sildenafil before they will authorize tadalafil for ED. Sildenafil is taken 30 to 60 minutes before sexual activity and lasts 4 to 6 hours. Tadalafil's 17 to 36 hour half-life is a meaningful clinical differentiator for men who prefer not to time dosing.

A 2018 meta-analysis in the European Urology journal (published via PubMed) that evaluated data from 82 trials covering 19,564 participants found that tadalafil and sildenafil showed comparable efficacy for ED, with International Index of Erectile Function (IIEF-EF) domain score improvements of approximately 6.5 to 8.5 points over placebo across both agents. The choice between them often comes down to tolerability and dosing convenience rather than clinical superiority.

Vardenafil and Avanafil

Vardenafil (Levitra, Staxyn) and avanafil (Stendra) are less commonly covered on Regence formularies and are more likely to appear at Tier 3 or non-formulary. Unless a patient has a documented intolerance to both sildenafil and tadalafil, these agents are unlikely to receive PA approval.

When Tadalafil Is Used Off-Label

Tadalafil has documented clinical use beyond ED and BPH. Physicians prescribe it off-label for Raynaud's phenomenon, certain types of pulmonary hypertension not covered by the standard Revatio dosing, and altitude sickness prophylaxis. Regence coverage for off-label uses requires a compelling body of clinical evidence and typically a formal medical exception request from a specialist rather than a standard PA. The NIH's clinical guidelines portal includes summaries of evidence for off-label PDE-5 use that a prescriber may reference when building a medical exception argument.

Testosterone Deficiency, ED, and Coverage Considerations

Some men seeking Cialis have an underlying low testosterone level driving their ED. If a serum total testosterone comes back below 300 ng/dL on two morning draws, a diagnosis of hypogonadism (ICD-10: E29.1) is supportable. Treating the underlying hypogonadism with testosterone replacement therapy may itself improve erectile function, and the diagnosis of hypogonadism is generally covered by Regence with fewer restrictions than ED alone.

The Endocrine Society's 2018 Clinical Practice Guideline on Testosterone Therapy recommends: "We suggest that clinicians consider offering testosterone therapy to men with symptomatic androgen deficiency and erectile dysfunction who desire testosterone therapy." When a prescriber documents both hypogonadism and ED, the insurance submission strategy can shift from purely ED-focused to a comorbidity-based argument that may fare better under Regence review criteria.

Practical Tips for Getting Regence to Cover Tadalafil

Getting coverage approved is largely a documentation challenge. These actions improve the odds.

Use the Correct ICD-10 Code

Submitting N52.9 (erectile dysfunction, unspecified) is weaker than N52.01 (erectile dysfunction due to arterial insufficiency) or N52.02 (corporo-venous occlusive erectile dysfunction) when an organic cause has been identified. More specific codes signal to the PA reviewer that a clinical workup was done. For BPH, N40.1 (BPH with lower urinary tract symptoms) is stronger than N40.0 (BPH without LUTS).

Include Comorbidity Documentation

Cardiovascular disease, type 2 diabetes, and neurological conditions such as multiple sclerosis are recognized organic causes of ED. A 2019 study in Diabetes Care documented ED prevalence of 52% in men with type 2 diabetes, well above the general population baseline. If a patient has diabetes and ED, the prescriber should document both diagnoses and the plausible causal link. This framing changes the coverage argument from "lifestyle drug" to "treatment of a complication of a chronic disease."

Request a Peer-to-Peer Review

If the initial PA is denied, the prescriber can request a peer-to-peer call with the Regence medical director responsible for the denial. Physicians report higher success rates in these calls than through written appeals alone, particularly when new clinical information is presented. This option is typically available within 72 hours of a denial and must be requested by the prescribing physician, not the patient.

Ask About Regence's Specialty Drug Exceptions Process

For cases where both standard PDE-5 inhibitors are documented as ineffective or contraindicated, Regence has a specialty exception pathway. This pathway is rarely needed for tadalafil but becomes relevant when a patient has a specific medical reason for needing a higher dose or an extended supply beyond the standard quantity limit.

ACA Marketplace Plans and ED Drug Coverage

The Affordable Care Act's essential health benefits (EHBs) framework does not classify ED medications as a required covered benefit. States retain the right to mandate coverage, but none of the Regence operating states (Idaho, Oregon, Utah, Washington) have passed mandates requiring coverage of ED drugs as of early 2025.

Oregon and Washington have both passed broader sexual health coverage expansions in recent years, but these expansions have focused on contraception and STI screening rather than PDE-5 inhibitors. The CDC's sexual health guidelines note that sexual health includes treatment of conditions affecting sexual function, but this framing has not yet translated into state insurance mandates for ED drug coverage in Regence's service area.